Pediatric endocrinology

The Late Effects of Hematopoietic Stem Cell Transplants in Pediatric Patients: A 25-Year Review

J Clin Endocrinol MetabPublished Retrospective review

Authors' conclusion

We confirm gonadal dysfunction, multiple endocrine and metabolic abnormalities, thyroid cancer, and SMNs as common sequelae of HSCT and identify gaps in management-particularly the need for informed fertility counseling and pretreatment fertility preservation, evaluation, and management of bone health-and underline the need for early lifestyle modification, long-term surveillance, and prospective planned studies aimed at reducing complication risk.

Study context

Population
Children and adolescents who received allogeneic hemopoietic stem cell transplant (HSCT) at Royal Children's Hospital Melbournestudy cohort of 384 HSCT recipients
Participants
228 children
Outcome
Incidence of endocrinopathies; fertility, growth, bone and metabolic status; subsequent malignant neoplasms (SMNs)
Methodological detailssingle-center
  • Single-center

Main finding

As reported in the abstract

Late effects of HSCT
Gonadotoxicity more common in females
P < .001
Spontaneous pregnancies in sexually active females
22%
Short stature common; GH axis disruption among these
30%
Thyroid nodules in patients exposed to thyroid radiation
51%
Malignant nodules
30%
Fragility fractures
6%
Avascular necrosis
6%
Subsequent malignant neoplasms (SMNs), risk continuing to rise throughout follow-up
Thirteen percent

Observational data: associations, not effects.

Original publication

The Late Effects of Hematopoietic Stem Cell Transplants in Pediatric Patients: A 25-Year Review. J Clin Endocrinol Metab. Published 27 March 2024. doi:10.1210/clinem/dgae196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.